Laureen Debuono

Laureen DeBuono serves as the Chair of the Audit Committee and a Board Member at Saluda Medical since October 2022, and has been a Partner at FLG Partners since October 2011, leading the firm as Managing Partner from 2020 to early 2025. DeBuono holds the position of Lead Independent Director and Chair of the Audit Committee at Rani Therapeutics until April 2025, and has previously held key executive roles including Chief Executive Officer and Board Member at govino, Interim Chief Financial Officer at HotelTonight, and Chief Operating Officer at Circa of America, LLC. Additional board experience includes roles at Turtle Beach, Rodan + Fields, Penhaligon's, and Cadence Pharmaceuticals. DeBuono's academic qualifications include a J.D. from New York University School of Law, an M.A. from Stanford University, and a B.A. from Duke University.